ArticleDrug design, development and therapy2022

Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma.

Magnus Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.